1465-6566 |
EXPERT OPINION ON PHARMACOTHERAPY |
CIÊNCIAS BIOLÓGICAS II |
A3 |
2017-2020 |
1473-7140 |
EXPERT REVIEW OF ANTICANCER THERAPY |
CIÊNCIAS BIOLÓGICAS I |
A3 |
2017-2020 |
1473-7140 |
EXPERT REVIEW OF ANTICANCER THERAPY |
CIÊNCIAS BIOLÓGICAS II |
A3 |
2017-2020 |
1473-7140 |
EXPERT REVIEW OF ANTICANCER THERAPY |
MEDICINA I |
A3 |
2017-2020 |
1473-7140 |
EXPERT REVIEW OF ANTICANCER THERAPY |
QUÍMICA |
A3 |
2017-2020 |
1473-7140 |
EXPERT REVIEW OF ANTICANCER THERAPY |
BIOTECNOLOGIA |
A3 |
2017-2020 |
1473-7140 |
EXPERT REVIEW OF ANTICANCER THERAPY |
INTERDISCIPLINAR |
A3 |
2017-2020 |
1473-7140 |
EXPERT REVIEW OF ANTICANCER THERAPY |
FARMÁCIA |
A3 |
2017-2020 |
1744-666X |
EXPERT REVIEW OF CLINICAL IMMUNOLOGY |
FARMÁCIA |
A3 |
2017-2020 |
1744-666X |
EXPERT REVIEW OF CLINICAL IMMUNOLOGY |
ODONTOLOGIA |
A3 |
2017-2020 |
1744-666X |
EXPERT REVIEW OF CLINICAL IMMUNOLOGY |
CIÊNCIAS BIOLÓGICAS III |
A3 |
2017-2020 |
1744-666X |
EXPERT REVIEW OF CLINICAL IMMUNOLOGY |
SAÚDE COLETIVA |
A3 |
2017-2020 |
1744-666X |
EXPERT REVIEW OF CLINICAL IMMUNOLOGY |
MEDICINA I |
A3 |
2017-2020 |
1744-666X |
EXPERT REVIEW OF CLINICAL IMMUNOLOGY |
MEDICINA II |
A3 |
2017-2020 |
1744-666X |
EXPERT REVIEW OF CLINICAL IMMUNOLOGY |
BIOTECNOLOGIA |
A3 |
2017-2020 |